Osmind is a pioneering public benefit corporation based in San Francisco that is dedicated to transforming mental health care through innovative, life-saving treatments. The company addresses the unique challenges faced by neuropsychiatric clinics with its specialized electronic health record (EHR) platform, tailored for interventional therapies such as transcranial magnetic stimulation, ketamine therapy, and psychedelic medicine. With a clear mission to enhance mental healthcare delivery and improve patient outcomes, Osmind actively engages in research initiatives and collaborates with esteemed institutions, including Stanford University, to establish new benchmarks in mental health interventions. Supported by prominent investors, Osmind merges scientific expertise with technological advancement to effectively confront the global mental health crisis.